EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Evaluation of the determinants of factor VIII and factor IX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) study

Laura L Swystun, Julie Grabell, Megan Hinds, Maria Avgeropoulos, Mackenzie Bowman, Megan Chaigneau, Kali de Repentigny, Mark Belletrutti, Wilma Hopman, Alfonso Iorio, Shannon Jackson, Arun Keepanasseril und 5 weitere

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2026.06.043 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Laura L Swystun und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen's University, Kingston, Ontario, Canada. Hauptthemen laut MEDLINE: Quality of Life, Hemophilia A, Factor VIII, Factor IX. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baxalta.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hemophilia carriers can experience abnormal bleeding and reduced health-related quality of life (HRQoL). Determinants of clinical phenotype remain unclear. OBJECTIVES: To identify modifiers of factor VIII (FVIII) and factor IX (FIX) levels, bleeding phenotype, and HRQoL in hemophilia carriers. METHODS: This cross-sectional study included 108 Canadian hemophilia carriers aged ≥18 years. Outcomes included Self-administered Bleeding Assessment Tool (Self-BAT) scores, 36-Item Short Form Health Survey, version 2 (SF-36v2) HRQoL, and joint health. Central laboratory testing assessed F8/F9 genotypes, factor levels, and ABO group. Associations were evaluated by nonparametric analyses, Spearman's rho, and multivariable regression. RESULTS: In hemophilia A carriers (N = 92), Self-BAT score correlated with FVIII coagulant activity (FVIII:C; rs = -0.298, 95% CI: -0.482 to -0.09). Participants with mild hemophilia A had lower mean von Willebrand factor (VWF) antigen (VWF:Ag; 82.8 IU/dL) than symptomatic (129.6) and asymptomatic carriers (164.2). VWF:Ag and VWF propeptide (VWFpp)/VWF:Ag ratio correlated with FVIII:C (rs = 0.622, 95% CI: 0.47-0.737) and Self-BAT score (rs = 0.255, 95% CI: 0.043-0.445). Blood type O was present in 83.3% of patients with mild hemophilia A, 59.1% of symptomatic carriers, and 37.5% of asymptomatic carriers and associated with 29.8% lower VWF:Ag, 15.2% lower FVIII:C, and 1.44-fold elevated VWFpp/VWF:Ag. Multivariable analysis confirmed associations between FVIII:C and VWF:Ag (β: 0.26; 95% CI: 0.17-0.34), Self-BAT score and FVIII:C (β: -0.06, 95% CI: -0.1 to -0.01), and Self-BAT score and ABO group (β: -2.73, 95% CI: -5.41 to -0.04). The SF-36v2 Physical Component Summary correlated with Self-BAT score (rs = -0.255, 95% CI: -0.444 to -0.044) and joint health (rs = -0.325, 95% CI: -0.512 to -0.111), while mental health domains were linked with feelings of guilt and burden. CONCLUSION: In hemophilia A carriers, FVIII:C and Self-BAT score associate with VWF and ABO group. A better understanding of these determinants may improve health-related outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeHemophilia AFactor VIIIFactor IXHemorrhageBlood CoagulationHumansCross-Sectional StudiesAdultMalePhenotypeCanadavon Willebrand FactorYoung AdultMiddle AgedAdolescentHeterozygoteMultivariate AnalysisSeverity of Illness IndexSurveys and QuestionnairesBiomarkersABO Blood-Group SystemGenotypeFemale

Stichwörter der Autor:innen

ABO blood group systemcarriersgenetichemophilia Ahemophilia Bvon Willebrand factor

Substanzen

Factor VIIIFactor IXvon Willebrand FactorF8 protein, humanBiomarkersABO Blood-Group System

Autor:innen und Institutionen

  • Department of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medicine, University of British Columbia, British Columbia, Canada.
  • Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Förderung

  • Baxalta

Zitieren

APA

Swystun, L. L., Grabell, J., Hinds, M., Avgeropoulos, M., Bowman, M., Chaigneau, M., de Repentigny, K., Belletrutti, M., Hopman, W., Iorio, A., Jackson, S., Keepanasseril, A., Leung, J., Robinson, S., Rydz, N., Sholzberg, M., & James, P. D. (2026). Evaluation of the determinants of factor VIII and factor IX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.06.043

Vancouver

Swystun LL, Grabell J, Hinds M, Avgeropoulos M, Bowman M, Chaigneau M, et al. Evaluation of the determinants of factor VIII and factor IX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) study. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.06.043

BibTeX
@article{Swystun2026,
  author = {Swystun, Laura L and Grabell, Julie and Hinds, Megan and Avgeropoulos, Maria and Bowman, Mackenzie and Chaigneau, Megan and de Repentigny, Kali and Belletrutti, Mark and Hopman, Wilma and Iorio, Alfonso and Jackson, Shannon and Keepanasseril, Arun and Leung, Jennifer and Robinson, Sue and Rydz, Natalia and Sholzberg, Michelle and James, Paula D},
  title = {Evaluation of the determinants of factor VIII and factor IX levels, bleeding score, and health-related quality of life in the Canadian hemophilia carriers (CHiC) study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2026.06.043}
}
Kostenlos starten →